pulmonary alveolar proteinosis | ClinicalTrials HQ

View definition

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A National Registry For Pulmonary Alveolar Proteinosis	lung disorder, pulmonary alveolar proteinosis, respiratory system disorder	Recruiting	Not stated	2026-03-17		NCT02461615
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).	autoimmune pulmonary alveolar proteinosis, lung disorder, pulmonary alveolar proteinosis, respiratory system disorder	Recruiting	Phase 3	2026-02-19		NCT06431776
Safety and Efficacy of PMT Therapy of hPAP	hereditary pulmonary alveolar proteinosis, lung disorder, pulmonary alveolar proteinosis, respiratory system disorder	Recruiting	Phase 1 / Phase 2	2025-12-19		NCT05761899
Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis	lung disorder, pulmonary alveolar proteinosis, respiratory system disorder	Not yet recruiting	Phase 2	2025-05-25		NCT06989333
European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eosinophilia, Fibrosis, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, Infant, Premature, Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Distress Syndrome, Newborn, adult acute respiratory distress syndrome, hematologic disorder, hypereosinophilic syndrome, interstitial lung disease, leukocyte disorder, lung disorder, pulmonary alveolar proteinosis, pulmonary eosinophilia, pulmonary fibrosis, respiratory system disorder	Recruiting	Not stated	2022-09-21		NCT02852928